Adipokines as Uremic Toxins

被引:32
|
作者
Teta, Daniel [1 ]
机构
[1] CHU Vaudois, Serv Nephrol, Dept Med, CH-1011 Lausanne, Switzerland
关键词
CHRONIC KIDNEY-DISEASE; ADIPONECTIN; HEMODIALYSIS; LEPTIN; RISK; RESISTIN;
D O I
10.1053/j.jrn.2011.10.029
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The adipose tissue has pleiotropic functions far beyond the mere storage of energy, and it secretes a number of hormones and cytokines, called adipokines, which have biological effects that impact heath and disease. Adipokines are markedly elevated in the plasma of uremic patients, mainly due to decreased renal excretion. They have pluripotent signaling effects on inflammation/oxidative stress (leptin, adiponectin, resistin), protein-energy wasting (leptin, adiponectin), insulin signaling (adiponectin, leptin, visfatin), endothelial dysfunction (visfatin), and vascular damage (adiponectin, leptin, resistin), which are prevalent in uremic patients. Obesity superimposed to uremia may further aggravate hyperadipokinemia, with the exception of adiponectinemia, which is mitigated by adiposity. Among adipokines and until more data become available, only leptin may be considered as a full uremic toxin owing to adverse effects on protein-energy wasting, cardiovascular damage, inflammation, and the immune system, which have been documented both clinically and experimentally. Resistin and visfatin display some features of uremic toxins, but more data are needed to consider these adipokines as true uremic toxins. In contrast, high levels of adiponectin and chemerin seen in uremia appear to be beneficial. Further research is needed to investigate whether selective removal of leptin, resistin, and visfatin and increments of adiponectin and chemerin levels may have clinical relevance in uremic patients. (C) 2012 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:81 / 85
页数:5
相关论文
共 50 条
  • [1] UREMIC TOXINS
    COHEN, BD
    AKTUELLE UROLOGIE, 1974, 5 (02) : 73 - 81
  • [2] UREMIC TOXINS
    BERGSTROM, J
    FURST, P
    KIDNEY INTERNATIONAL, 1978, : S9 - S12
  • [3] UREMIC TOXINS
    BALESTRI, PL
    BIAGINI, M
    RINDI, P
    GIOVANNETTI, S
    ARCHIVES OF INTERNAL MEDICINE, 1970, 126 (05) : 843 - +
  • [4] Uremic toxins
    Vanholder, R
    NEPHROLOGIE, 2003, 24 (07): : 373 - 376
  • [5] UREMIC TOXINS
    COHEN, BD
    BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 1975, 51 (11) : 1228 - 1234
  • [6] The removal of uremic toxins
    Dhondt, A
    Vanholder, R
    Van Biesen, W
    Lameire, N
    KIDNEY INTERNATIONAL, 2000, 58 : S47 - S59
  • [7] Searching for Uremic Toxins
    Dobre, Mirela
    Meyer, Timothy W.
    Hostetter, Thomas H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (02): : 322 - 327
  • [8] A PERSPECTIVE ON UREMIC TOXINS
    BLACK, DAK
    ARCHIVES OF INTERNAL MEDICINE, 1970, 126 (05) : 906 - &
  • [9] An update on uremic toxins
    N. Neirynck
    R. Vanholder
    E. Schepers
    S. Eloot
    A. Pletinck
    G. Glorieux
    International Urology and Nephrology, 2013, 45 : 139 - 150
  • [10] Nondialyzable Uremic Toxins
    Piroddi, Marta
    Bartolini, Desiree
    Ciffolilli, Silvia
    Galli, Francesco
    BLOOD PURIFICATION, 2013, 35 : 30 - 41